NCT02511262View on ClinicalTrials.gov

Detection of Mycoplasma Pneumoniae

CompletedOBSERVATIONAL
Enrollment

471

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Conditions
Mycoplasma Pneumoniae
Interventions
DEVICE

illumigene® Mycoplasma Direct, illumipro-10

DNA amplification assay

Trial Locations (3)

32513

Sacred Heart Health System, Pensacola

64108

The Children's Mercy Hospital, Kansas City

76104-2796

Cook Children's Healthcare System (CCHCS), Fort Worth

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY